Tissue Therapies

Tissue Therapies (TIS)

Stock Code

TIS

Stock Exchange

ax

Tissue Therapies (TIS) is biotechnology company that provides wound healing, tissue repair and cell culture technology through a growth factor platform technology VitroGro®. TIS was incorporated in 2003 and listed on the Australian stock market (ASX) in March 2004. Its head office is situated in Brisbane. The company has agreements with a number of international companies to commercialise its VitroGro® technology.

Tissue Therapies Dividends

18 October, 2010 - 01:15

Research the list of dividend records for Tissue Therapies. Dividends are a portion of company profits paid out to shareholders. If Tissue Therapies Limited has announced a dividend, you may be eligible to receive TIS dividends if the share trader the company's shares on the ex-dividend date. In order to receive the dividend payout, investors must purchase the shares before the ex dividend date. The previous owner of the shares will receive the dividend if you buy the stocks on or after the ex dividend date.

Syndicate content

Recommended Websites